Cite
Permissive regulation: How North America's regulation of buprenorphine supported manufacturer profits over equitable access
MLA
McGee, Meghan. “Permissive Regulation: How North America’s Regulation of Buprenorphine Supported Manufacturer Profits over Equitable Access.” Annals of Family Medicine, vol. 21, no. S1, Jan. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.737170586&authtype=sso&custid=ns315887.
APA
McGee, M. (2023). Permissive regulation: How North America’s regulation of buprenorphine supported manufacturer profits over equitable access. Annals of Family Medicine, 21(S1).
Chicago
McGee, Meghan. 2023. “Permissive Regulation: How North America’s Regulation of Buprenorphine Supported Manufacturer Profits over Equitable Access.” Annals of Family Medicine 21 (S1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.737170586&authtype=sso&custid=ns315887.